These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

652 related items for PubMed ID: 2899295

  • 1. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.
    Hirsch E, Graybiel AM, Agid YA.
    Nature; 1988 Jul 28; 334(6180):345-8. PubMed ID: 2899295
    [Abstract] [Full Text] [Related]

  • 2. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 3. Evidence for neuromelanin involvement in MPTP-induced neurotoxicity.
    D'Amato RJ, Alexander GM, Schwartzman RJ, Kitt CA, Price DL, Snyder SH.
    Nature; 2006 Jun 19; 327(6120):324-6. PubMed ID: 2884568
    [Abstract] [Full Text] [Related]

  • 4. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
    Herrero MT, Hirsch EC, Kastner A, Ruberg M, Luquin MR, Laguna J, Javoy-Agid F, Obeso JA, Agid Y.
    Neuroscience; 1993 Sep 19; 56(2):499-511. PubMed ID: 8247275
    [Abstract] [Full Text] [Related]

  • 5. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.
    Brain; 2005 Nov 19; 128(Pt 11):2654-64. PubMed ID: 16000336
    [Abstract] [Full Text] [Related]

  • 6. Neuropharmacological manipulations with MPTP.
    Barnes NJ, Bradbury AJ, Costall B, Domeney AM, Kelly ME, Naylor RJ.
    J Neural Transm Suppl; 1986 Nov 19; 20():47-63. PubMed ID: 3091761
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.
    Dong Z, Ferger B, Feldon J, Büeler H.
    J Neurobiol; 2002 Oct 19; 53(1):1-10. PubMed ID: 12360578
    [Abstract] [Full Text] [Related]

  • 8. [Metabolic activation of azaheterocyclics induced dopaminergic toxicity: possible candidate neurotoxins underlying idiopathic Parkinson's disease].
    Matsubara K.
    Nihon Hoigaku Zasshi; 1998 Oct 19; 52(5):301-5. PubMed ID: 10077975
    [Abstract] [Full Text] [Related]

  • 9. The enigma of neuromelanin in Parkinson's disease substantia nigra.
    Youdim MB, Ben-Shachar D, Riederer P.
    J Neural Transm Suppl; 1994 Oct 19; 43():113-22. PubMed ID: 7884393
    [Abstract] [Full Text] [Related]

  • 10. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P, Marsden CD.
    J Neural Transm Suppl; 1986 Oct 19; 20():11-39. PubMed ID: 3091760
    [Abstract] [Full Text] [Related]

  • 11. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
    Kastner A, Herrero MT, Hirsch EC, Guillen J, Luquin MR, Javoy-Agid F, Obeso JA, Agid Y.
    Ann Neurol; 1994 Aug 19; 36(2):206-14. PubMed ID: 7914399
    [Abstract] [Full Text] [Related]

  • 12. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK, Choi BH, Huang X, Snyder BJ, Bukhari S, Kong TH, Park H, Park HC, Park SR, Ha Y.
    Eur J Neurosci; 2009 Mar 19; 29(5):891-900. PubMed ID: 19245369
    [Abstract] [Full Text] [Related]

  • 13. Neuromelanin and Parkinson's disease.
    Marsden CD.
    J Neural Transm Suppl; 1983 Mar 19; 19():121-41. PubMed ID: 6321645
    [Abstract] [Full Text] [Related]

  • 14. Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.
    Fedorow H, Tribl F, Halliday G, Gerlach M, Riederer P, Double KL.
    Prog Neurobiol; 2005 Feb 19; 75(2):109-24. PubMed ID: 15784302
    [Abstract] [Full Text] [Related]

  • 15. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS, Brown EM, Miller MS, Carswell S.
    J Pharmacol Exp Ther; 1999 Feb 19; 288(2):421-7. PubMed ID: 9918541
    [Abstract] [Full Text] [Related]

  • 16. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ, Batchelor PE, Howells DW.
    Exp Neurol; 2005 Mar 19; 192(1):226-34. PubMed ID: 15698637
    [Abstract] [Full Text] [Related]

  • 17. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
    Liang CL, Nelson O, Yazdani U, Pasbakhsh P, German DC.
    J Comp Neurol; 2004 May 17; 473(1):97-106. PubMed ID: 15067721
    [Abstract] [Full Text] [Related]

  • 18. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
    Schmidt N, Ferger B.
    Synapse; 2001 Apr 17; 40(1):47-54. PubMed ID: 11170221
    [Abstract] [Full Text] [Related]

  • 19. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K, Pitzer C, Teismann P, Krüger C, Göricke B, Laage R, Lingor P, Peters K, Schlachetzki JC, Kobayashi K, Dietz GP, Weber D, Ferger B, Schäbitz WR, Bach A, Schulz JB, Bähr M, Schneider A, Weishaupt JH.
    J Neurochem; 2006 May 17; 97(3):675-86. PubMed ID: 16573658
    [Abstract] [Full Text] [Related]

  • 20. Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease.
    McRitchie DA, Cartwright HR, Halliday GM.
    Exp Neurol; 1997 Mar 17; 144(1):202-13. PubMed ID: 9126172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.